Intriguingly, we noted reduced GPR15 expression on tumor infiltrating CD4+ and CD8+ T cells in GPR15L-treated Gpr15-Het mice compared to the PBS-treated Gpr15-Het mice. Here, GPR15LG is linked to neoplasm.